This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Forness, S. R. Articles by Kavale, K. A. Search for Related Content PubMed PubMed Citation Articles by Forness, S. R. Articles by Kavale, K. A. Social Bookmarking                         What's this?

Psychopharmacologic Treatment

A Note on Classroom Effects

Steven R. Forness, EdD, is aprofessor in the Mental Retardation and Child Psychiatry Program and principal of the Neuropsychiatric Inpatient School at the University of California, Los Angeles. Address: Steven R Forness, UCU Neuropsychiatric Hospital. 760 Westwood Plaza, Los Angeles, CA 90024.

Kenneth A. Kavale

Kenneth A. Kavsle, PhD, is professor and chair, Division of Special Education, at the University of Iowa.

Although significant numbers of children with learning or behavioral disorders may be receiving psychopharmacologic medications, special education personnel may not always be familiar with either specific therapeutic effects or side effects of such drugs. The following is a brief introduction to specific classroom issues involved in the four major classes of psychotropic medication, along with certain recent methodological concerns in both research and classroom intervention in this area.

Journal of Learning Disabilities, Vol. 21, No. 3, 144-147 (1988)
DOI: 10.1177/002221948802100304


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. B. Ryan, R. Reid, and C. Ellis Special Educators' Knowledge Regarding Psychotropic Interventions for Students With Emotional and Behavioral Disorders Remedial and Special Education, September 1, 2008; 29(5): 269 - 279. [Abstract] [PDF]

				V. E. Snider, T. Busch, and L. Arrowood Teacher Knowledge of Stimulant Medication and ADHD Remedial and Special Education, January 1, 2003; 24(1): 46 - 56. [Abstract] [PDF]

				D. P. Sweeney, S. R. Forness, K. A. Kavale, and J. G. Levitt An Update on Psychopharmacologic Medication: What Teachers, Clinicians, and Parents Need to Know Intervention in School and Clinic, September 1, 1997; 33(1): 4 - 21. [Abstract] [PDF]

				S. R. Forness, J. M. Swanson, D. P. Cantwell, D. Youpa, and G. L. Hanna Stimulant Medication and Reading Performance: Follow-up on Sustained Dose in ADHD Boys with and Without Conduct Disorders J Learn Disabil, February 1, 1992; 25(2): 115 - 123. [Abstract] [PDF]

				S. R. Forness, D. P. Cantwell, J. M. Swanson, G. L. Hanna, and D. Youpa Differential Effects of Stimulant Medication on Reading Performance of Boys With Hyperactivity With and Without Conduct Disorder J Learn Disabil, May 1, 1991; 24(5): 304 - 310. [Abstract] [PDF]

				K. J. Rooney Controversial Therapies: A Review and Critique Intervention in School and Clinic, January 1, 1991; 26(3): 134 - 142. [Abstract] [PDF]

				N. N. Singh, M. H. Epstein, J. Luebke, and Y. N. Singh Psychopharmacological Intervention I: Teacher Perceptions of Psychotropic Medication for Students with Serious Emotional Disturbance Journal of Special Education, January 1, 1990; 24(3): 283 - 295. [Abstract] [PDF]